Toshiba Dose Tracking System awarded Novation’s Innovative Technology Designation


Toshiba America Medical Systems’ Dose Tracking System (DTS) was awarded the Innovative Technology designation by Novation at its Innovative Technology Expo.

Toshiba’s DTS provides a real-time display that tracks cumulative skin dose distribution, as well as peak skin dose, to provide a safer exam for patients. In addition, enhancements such as expanded bi-plane (frontal and lateral) coverage and enhanced ability to account for tilt and cradle table movement help clinicians track and measure peak skin dose, giving customers the confidence that they are providing the safest, best approach to diagnoses and treatment.

DTS was awarded the Innovative Technology designation following a review by more than 200 attendees from hospitals around the USA who serve on a Novation council or task force and participated in the expo. These key opinion leaders indicated that Toshiba’s DTS offered incremental benefits over other products available on the market.

“Toshiba’s DTS helps provide a safer patient exam, allowing clinicians to focus on accurate diagnosis and better care,” says Olya Carter, senior clinical manager at Novation. “DTS’ 85% approval rating from attendees reflects the technology’s benefit to patient safety and its effectiveness.”

“Our customers rely on fast, accurate data to make real-time diagnoses and decisions,” comments David Sloop, director, x-ray vascular business unit, Toshiba. “DTS is a first-of-its-kind technology that improves patient safety and experience, as well as giving clinicians confidence that their decisions are backed by solid data to keep their patients safe and procedures effective.”